Clinical Trial

Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated July 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma. Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla. Methods: This study will be carried out as a randomized
Trial Details
NCT Number NCT07150858
Lead Sponsor Alexandria University
Conditions Sinus Lifting
Enrollment 20 participants
Start Date 2025-05-25
Primary Completion 2026-07-25 (estimated)
Study Completion 2026-07-25 (estimated)
Updated on ClinicalTrials.gov 2025-09-02